ARTICLES
Longevity Meets AI Meets Stem Cells
By Eve Herold - An AI for longevity? Yes, please. Open AI’s CEO Sam Altman is all in on the search for longer lifespans, and he’s putting his money where his mouth is. In 2023, he donated $180 million to Retro Biosciences, a healthcare startup seeking to extend life...
The Holy Grail: Reversing Alzheimer’s?
By Eve Herold - Often by the time AD patients display symptoms, it’s too late to benefit from treatment. The holy grail in treating Alzheimer’s is finding a way to not only arrest its relentless march but to reverse damage to neurons and synapses once it develops. And...
A Moon Shot for Aging (Literally)
By Eve Herold - A Silicon Valley startup owned by Mitrix Bio plans to begin the first age-reversal trial in human volunteers later this year. What does this have to do with the moon? The study is first aimed at helping astronauts withstand the high-radiation,...
Here Come the Anthrobots
By Eve Herold - Is it my imagination, or are the classifications for useful types of robots growing by leaps and bounds? First there were robots, then bots, chatbots, nanobots, biobots, xenobots and well, now there are living, self-assembling anthrobots made of human...
Precursor Amniotic Fluid Cells Taken to the Next Level
By Eve Herold - Amniotic fluid is rich in precursor cells shed by the fetus, according to UK researchers, and those cells can be used to develop tissue-specific organoids for studying congenital defects and rare diseases. While genetic testing of cells in the amniotic...
How Smart Should Robots Be?
By Eve Herold - Time - Ideas • Technology - January 9, 2024 When people hear the words “social engineering,” they usually think of the supposed nefarious designs of government or an opposing political party. These days, there’s a general sense of social upheaval...